
Approval of a novel antibody-drug conjugate ushers in new second-line option.
Approval of a novel antibody-drug conjugate ushers in new second-line option.
Academic and industry partnership to investigate new approach to treating lethal pancreatic cancer.
These agents are likely to become the mainstay of cancer treatment in the very near future.
Branding Move and Leadership Additions Part of Effort to Deliver “One City of Hope” Experience to Patients Across National Clinical Network.
Moderator Curtis E. Haas, PharmD, FCCP; Deborah Simonson, PharmD; Andrew J. Donnelly, PharmD, MBA, FASHP; Noelle Chapman, PharmD, MBA, BCPS, FASHP; Todd Nesbit, PharmD, MBA, FASHP, discuss current challenges facing health-system pharmacies as well as potential solutions in areas such as staffing and financial stress.
New UC Davis study finds relationship between tumor microbiome and immune system in patients with soft tissue sarcoma.
Luke Gormley, PharmD, BCPS, discusses how pharmacists are involved in the management of inclisiran.
Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial
AON celebrates its Board of Managers’ appointments and retirements.
Many patients have baseline risk factors present at diagnosis because of older age and disease-related elements.
Participants Will Attend PQA Annual Meeting, Have Access to More Than 20 Hours of Training.
To help advance patient care and address health equities for underserved communities, McKesson is investing in certified pharmacy technicians who are passionate about making a difference.
The incidence of vancomycin-resistant enterococci has nearly doubled in recent years.
Significant study results may help inform clinical practice strategies.
Developments may soon impact clinical practice in hematology and oncology.
Researchers question screening guidelines for older women after findings.
Michael Brown, vice president of Managed Services at Cardinal Health, discusses ways for pharmacists to help manage costs post-pandemic.
Stephen Davis, PharmD, senior director of Health System Strategy at Shields, and Erica Diamantides, PharmD, specialty pharmacy manager at UW Medicine, discuss the current guidance and best practice for specialty pharmacy accreditations.
Survey shows pharmacies could implement more point-of-care testing and have a large pool of willing participants.
Pharmacological options for those who experience migraines come in the form of abortive or preventative therapies.
UC Davis study shows Californians diagnosed with cancer have higher current tobacco use.
Patient-controlled analgesia typically consists of opioids or local anesthetics, but it may also include non-opioid analgesics or other medications.
UC Davis cancer researchers hope new technology will help diagnose and treat melanoma more successfully.
Center will serve as a hub for commercialization of promising cancer therapies.